Umdlali wexesha elide uJacob Coburn uthi uncediso luphilise i-RA
Kwi-interview yakhe emva kokuphumelela i-Oscar ngo-1999, umdlali wezilwanyana uJames Coburn uthetha ukulwa neminyaka eyi-15 yokulwa ne- rheumatoid arthritis . Wawuthatha uMdlali ongcono kuMsebenzi oxhasayo emsebenzini wakhe kwi-movie ethi "Uxinzelelo." Uluntu lwama-arthritis lwavuselelwa ngamabango uCoburn kwaye abantu babememeza ngenjongo yokufunda malunga nonyango awathethileyo.
Izidalwa ngokuqhelekileyo zinika ingqwalasela engakumbi kunabangabonwayo. Akumangalisi ukuba xa uJacob Coburn ecinga ukuba wayekwazi "ukufikelela kwingcambu yengxaki," abantu baphulaphula. Xa ukhangela icebo lonyango uCoburn uthetha ngalo, kubalulekile ukuhlaziya oko unokuqwalasela xa ukhetha icebo lonyango.
Ibango likaJames Coburn
Njengoko i- USA Today ne- Entertainment Weekly ibikwa ngu- USA Today , uJames Coburn wachaza ixesha eliyiminyaka eyi-10 xa ukunyakaza kubangelwa intlungu engenakunzima nokuma "kwakunzima kakhulu." Ngo-1990, uCoburn wayengenakuhambahamba ngenxa ye-rheumatoid arthritis kwaye yachaphazela umsebenzi wakhe njengomdlali. Waphoqeleka ukuba afake umsebenzi wakhe.
UCoburn wayenakuvuyela ukusekwa kwezonyango. Ukukholelwa ukuba abanakuyicombulula ingxaki yakhe, wayeka oogqirha. Emva kokugqiba engqondweni yakhe ukuba oogqirha bafuna ukugcina izigulane kwiidakamizwa kwaye kungaphilisi ingxaki, wathatha izinto ezandleni zakhe.
UCoburn wagxininisa kwisicwangciso sonyango esidibanisa i-massage yezicubu ezinzulu, unyango lwe-electromagnetic, kunye ne- MSM (i-methylsulfonylmethane) eyathi "ngokwenene, uyayenza loo msebenzi." Utsho uCoburn wasebenzisa igama elithi "unyango" kwiingxelo zakhe. Umdlali we-actor wafa ngo-2002 ngentliziyo.
Yintoni i-MSM (Methylsulfonylmethane)?
I-MSM isondlo esisemgangathweni esitholakala kwi:
- I zityalo
- Ukutya
- Iimveliso zederi
- Izithelo nemifuno
I-MSM ke itholakala kwisondlo esivamile. Kuyinto engenasiphelo, engenakunqwenela, emhlophe emanzini amfumfele, i-crystalline eqinile kwifomu layo ecocekileyo.
Ngaba i-MSM inceda iArthritis?
Olunye uphando lucebise ukuba ubuncinci be-MSM bufuneka emzimbeni ukugcina umsebenzi kunye nesakhiwo esiqhelekileyo. Izazinzulu azikazi imisebenzi eyiyo ye-MSM emzimbeni. Izigqibo ezenziwa malunga ne-MSM njengonyango lweengxaki zezifo, kuquka i-arthritis, azizange ziqinisekiswe ngophando lweklinikhi.
Akukho zicwangciso zokutya ezicetyiswayo zokutya ezimiselwe sulfure. Izidlo ezininzi zaseNtshona ziphezulu kwiiprotheyini, eziqulethe isulfure, ngoko akunakwenzeka ukuba ukusilela kwesulfure kukhona ekudleni kwabantu abaninzi.
Iziphumo zophando lwe-MSM
Nangona kuye kwadumeka ngokuthengiswa njengokongeza kwiminyaka emashumi ukususela kubungqina bukaCoburn, kukho uphando oluncinane olushicilelwe kwi-MSM, kwaye oko kukhoyo kukho i-osteoarthritis, kungekhona i-rheumatoid arthritis. Ukuphononongwa kwezilingo ezilawulwa ngokungapheliyo kufumaneke "Ububungqina obuhle kodwa obungengqalileyo bokuthi i-MSM iphezulu kune-placebo kwonyango oluthatyathwe kwi-osteoarthritis yamadolo." Imiphumo ebonwe kwilingo elilawulwa ngononophelo ka-2011 yayincinci yokuphucula intlungu kunye nokusebenza ngokomzimba kwizigulane ezine-osteoarthritis zamadolo.
Nangona abanye bakholelwa ukuba i-MSM ibe nesiseko sobunzululwazi, ubungqina abukwanele ukuba bhengeze njengokonyango lwe-arthritis .
Ukuqwalasela
Akukho kwisigulana esifanelekileyo somgudu ukuyeka unyango lwangoku ukuze uzame unyango olutsha olusekelwe kuphela kwiingqinisiso. Izongezelelo zondlo kunye nezinye iindlela zonyango azidingeki ukuba zihlolwe ngokunyanisekileyo njengenzululwazi ye-FDA. Isigulane akufanele sifake ukuxhaswa kwesondlo kwimiqathango yonyango ngaphandle kokubonisana nodokotela wabo kuqala.
Akukho nonyango eyaziwayo ye-rheumatoid arthritis. Kukho iindlela ezininzi zokonyango ezikhoyo ukukhupha iimpawu kwaye sinethemba lokuba ukunyuka kwesifo eso sihamba kodwa igama elithi "unyango" lilahlekisa ngokucacileyo.
> Imithombo:
> UBrien S, uPscott P, uBashir N, Lewith H, Lewith G. Ukuhlaziywa kwesistim yokuncedisa okunomsoco i-dimethyl sulfoxide (i-DMSO) kunye ne-methylsulfonylmethane (MSM) kunyango lwe-osteoarthritis. I-Osteoarthritis kunye neKartilage . 2008; 16 (11): 1277-1288. i-doi: 10.1016 / j.joca.2008.03.002.
> Debbi EM, Agar G, Fichman G, et al. Ukusebenza kwe-methylsulfonylmethane ukuxhaswa kwi-osteoarthritis yamadolo: isifundo esilawulwa ngokungahleliwe. I-BMC Complementary and Alternative Medicine . 2011; 11 (1). i-doi: 10.1186 / 1472-6882-11-50.